France tightens acitretin prescribing rules over pregnancy concerns
This article was originally published in Scrip
Executive Summary
The French regulatory agency ANSM is taking further steps to tighten up on the use of the retinoid acitretin for psoriasis and other skin conditions, after a study showed that women were regularly being prescribed the highly teratogenic drug without having a pregnancy test, and that 357 pregnancies were reported in women taking the product.